trial · primary record
Nivolumab
Locally Advanced Rectal Cancer
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 10 |
| Primary completion | 2030-12 |
| Primary endpoint | Pathologic complete response (pCR) |
| Registry ID | NCT07645118 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:40:56.829Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07645118
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.